Source comparison
Melanotan-1 vs MT-1: Naming Comparison
MT-1 Laboratory shorthand (University of Arizona, 1981) Academic research publications, peptide supplier catalogs N/A (not a formal drug name) Identical to Melanotan-1 and afamelanotide Melanotan-1 Clinical development identifier (1990s) Peptide research, inve
This comparison does not assign a generated winner or score.
- MT-1
- Laboratory shorthand (University of Arizona, 1981)
- Academic research publications, peptide supplier catalogs
- N/A (not a formal drug name)
- Identical to Melanotan-1 and afamelanotide
- Melanotan-1
- Clinical development identifier (1990s)
- Peptide research, investigational protocols
- Investigational (non-approved formulations)
- Identical to MT-1 and afamelanotide
- Afamelanotide
- International Nonproprietary Name (INN, 2008)
- Approved pharmaceutical product (Scenesse)
- EMA-approved for EPP (2014); FDA orphan drug (2019)
- Identical to MT-1 and Melanotan-1
- CAS 75921-69-6
- Chemical Abstracts Service registry
- Universal chemical identification across databases
- N/A (registry number, not drug status)
- Definitive identifier. All three names resolve to this CAS